Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |